Spanish Registry of Esophagogastric Cancer
AGAMENON-SEOM Study: Spanish Registry of Esophagogastric Cancer
Fundación Sociedad Española de Oncologia Médica
10,000 participants
Apr 27, 2020
OBSERVATIONAL
Conditions
Summary
This study aims to development of a database through a web page for epidemiological and clinical research purposes that is accessible to members of the AGAMENON - SEOM group that guarantees a rigorous collection, exploitation and analysis of the data and information contained, increases the knowledge of esophageal and stomach cancer in order to optimize the management, treatment and evolution of patients, the possibility of comparing variables with those of other series or groups, and promotes the quality of scientific publications.
Eligibility
Inclusion Criteria2
- Adult patient (≥18 years) diagnosed with carcinoma of the esophagus, gastroesophageal junction and stomach, including all histologic subtypes, with or without erbB2 overexpression (and tumors in which this data is unknown).
- Follow-up of at least 3 months with clinical information during this period, exempting patients with early death from any cause.
Exclusion Criteria1
- A patient for whom, for whatever reason, the information necessary to complete the database cannot be known or obtained.
Interventions
Surgery
Chemotherapy, anti-targeted agents and immunotherapy
Radiotherapy
Locations(38)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04958720